Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQL Block for Laparoscopic Hysterectomy
NCT03650998Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Zealand University Hospital. Primary endpoint: Postoperative opioid consumption at 12 hours. Started Sep 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03650998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03650998.